Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.
about
Clinical use and mechanisms of infliximab treatment on inflammatory bowel disease: a recent updateAlterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseasesPrevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorDiminished macrophage apoptosis and reactive oxygen species generation after phorbol ester stimulation in Crohn's disease.Defective apoptosis in intestinal and mesenteric adipose tissue of Crohn's disease patientsProbiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinaseDistinct patterns of mucosal apoptosis in H pylori-associated gastric ulcer are associated with altered FasL and perforin cytotoxic pathways.Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease.Cell death and inflammatory bowel diseases: apoptosis, necrosis, and autophagy in the intestinal epithelium.p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling.Impaired deoxyribonuclease I activity in patients with inflammatory bowel diseases.Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis.An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease.Is the Prevalence of Celiac Disease Higher than the General Population in Inflammatory Bowel Diseaese?Review article: the role of nutrition in the treatment of inflammatory bowel disease.T cell apoptosis and inflammatory bowel disease.Apoptosis and inflammation: role of adipokines in inflammatory bowel disease.Immunopathogenesis of Crohn's disease.Disturbances in apoptosis of lamina propria lymphocytes in Crohn's disease.Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis.Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?Apoptosis as a therapeutic tool in IBD?Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.Recent understanding of IBD pathogenesis: implications for future therapies.Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?The involvement of the apoptosis-modulating proteins ERK 1/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo.Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases.Life and death in the gut: more killing, less Crohn's.Novel monoclonal antibody-based Helicobacter pylori stool antigen test.High prevalence of celiac disease among patients affected by Crohn's disease.Epidemiology of Helicobacter pylori infection in the Czech Republic.Increased lymphocyte apoptosis in mouse models of colitis upon ABT-737 treatment is dependent upon BIM expression.Role of DOR-β-arrestin1-Bcl2 signal transduction pathway and intervention effects of oxymatrine in ulcerative colitis.In vivo proliferation of rat lamina propria T lymphocytes: general hyporesponsiveness but increased importance of the CD2 and CD28 pathways.What is the role of apoptosis in the normal and inflamed intestine?Apoptosis resistance of mucosal lymphocytes and IL-10 deficiency in patients with steroid-refractory Crohn's disease.Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease.
P2860
Q26994776-D7EB43D6-EF38-4D4D-A5B5-94422D5AEC78Q27016000-90111DD0-49B6-4BFF-91C7-330311E5A2C4Q27022976-C21CA831-E769-4CC7-BE1E-C46B4CDF5302Q30882939-69C1D282-5986-4F06-98A1-50B613164B87Q33699974-7B95F277-D0BD-4BE0-8DCE-BC14DAA0771BQ33847243-B48BAC02-8267-4065-8E9C-CE53D2687A54Q33868987-9D669FD4-846F-4967-8A57-631E86B85EB7Q33914228-09DC5E7A-91F2-432A-A50E-A2D7A89BA062Q34003160-E2112EA4-DFE7-42F0-97F7-D7D6AD053F5CQ34791990-A4D54C96-9CDC-422F-BFB7-7430CB3908DBQ35038880-ED4A88BD-89BB-4BE6-B07E-6E741175464BQ35594988-6A89C215-0F1C-465A-9B3C-413C56CA0587Q35596317-68AF2534-1D7E-47FC-AFCD-DFC7C7B43816Q35596945-E3A54BD8-240D-4B74-AFD2-988AEE376ECAQ35596974-1A644363-BBEA-44D8-A52D-CD537BCC0B22Q35603888-747CA434-4989-447E-9BB8-3236D561C4DBQ35880408-7650F187-61C8-4A67-9B66-D4DF7DA93FCEQ35915896-305D39DD-4097-417F-BFA2-44871130DDEFQ36002733-DDA8B0CE-4173-4A7B-9044-B0C2F99AE3EFQ36175758-C27C5634-EE74-4059-8E1A-B31A8B3B0779Q36418973-9EBBA7BE-18D8-4EDD-9AD9-DA03669B3E01Q36474134-FAB326C5-1792-4044-97F1-C17ADC6B105FQ36587155-0618603B-9E79-4CE4-9596-D2F1A985388DQ36631420-08766916-83DC-4A01-B78B-4F1F3BC6A296Q36631430-3E3C48A0-5202-4DDD-95FF-DB7CE7CC07AFQ36631434-701C6525-9890-4396-A4F3-A8C9951C2A01Q36639759-8F7F704A-4F5E-4C7D-840D-414AB405A52FQ38191334-48A65BEC-D8AF-4D99-8C21-196BB52CC571Q38404632-DCDB9EE4-0D55-48F6-AA80-B26A8AD79AA9Q39017821-38D624EF-EF63-40A5-8D02-89E40ABAA0F0Q43006478-352A215F-C128-40C1-AB43-D17DDB12D26AQ44912267-B3D4407A-14CD-46F1-BF7D-362B3FC17777Q46562246-F356E81A-9772-4750-9EC3-6E6F4A900012Q47654024-F2022733-D4BB-4115-B0FE-F7B4151814A3Q50743251-2D84D250-9121-4CFA-A698-A51855B1D061Q51311354-3CAEACB3-025D-4F59-9675-94AD534B18FFQ52908017-93827424-8D8C-428E-828A-7C60F987C28EQ52915690-9EBE03A3-63B3-41D5-B65A-1D23098C7E8CQ54364656-2B0AB405-5E67-46D0-A595-BA527C6E3A23Q54466275-FB4F46C1-A86E-4161-97E0-7BF3C7790515
P2860
Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@ast
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@en
type
label
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@ast
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@en
prefLabel
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@ast
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@en
P2093
P2860
P356
P1433
P1476
Decreased Bax expression by mu ...... apoptosis in Crohn's disease.
@en
P2093
P2860
P356
10.1136/GUT.49.1.35
P407
P577
2001-07-01T00:00:00Z